Therapeutic vaccines based on genetically modified Salmonella: A novel strategy in cancer immunotherapy

Polskie Archiwum Medycyny Wewnetrznej

Volumn 121, Issue 12, 2011, Pages 461-467

  Chorobik, Paulina ^a   Marcinkiewicz, Janusz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Cancer immunotherapy; Salmonella typhimurium VNP20009; Vaccine vector

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYCLOPHOSPHAMIDE; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESOTHELIN; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL COLONIZATION; BACTERIAL GENOME; CANCER IMMUNOTHERAPY; CHEMOTAXIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DEPIGMENTATION; HUMAN; ISCHEMIA; LISTERIA MONOCYTOGENES; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MESOTHELIOMA; MULTIMODALITY CANCER THERAPY; NONHUMAN; PANCREAS CANCER; PHAGOCYTOSIS; REVIEW; SALMONELLA TYPHIMURIUM; TRANSGENIC ORGANISM; TUMOR MODEL; UTERINE CERVIX CANCER;

EID: 84855268043     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1117     Document Type: Review

References (34)

1. Finn OJ. Cancer vaccines: between the idea and the reality. Nat Rev Immunol. 2003; 3: 630-641. (Pubitemid 37328666)
2. Redondo P, del Olmo J, López-Diaz de Cerio A, et al. Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions. J Invest Dermatol. 2007; 127: 1673-1680. (Pubitemid 46933436)
3. Guo J, Zhu J, Sheng X, et al. Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma. Int J Cancer. 2007; 120: 2418-2425. (Pubitemid 46642129)
4. Ahmad S, Casey G, Cronin M, et al. Induction of effective antitumor response after mucosal bacterial vector mediated DNA vaccination with endogenous prostate cancer specific antigen. J Urol. 2011; 186: 687-693.
5. Manuel ER, Blache CA, Paquette R, et al. Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumors. Cancer Res. 2011; 71: 4183-4191.
6. Zhu X, Zhou P, Cai J, et al. Tumor antigen delivered by Salmonella III secretion protein fused with heat shock protein 70 induces protection and eradication against murine melanoma. Cancer Sci. 2010; 101: 2621-2628.
7. Yam C, Zhao M, Hayashi K, et al. Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer. J Surg Res. 2010; 164: 248-255.
8. Cao HD, Yang YX, Lü L, et al. Attenuated Salmonella typhimurium carrying TRAIL and VP3 genes inhibits the growth of gastric cancer cells in vitro and in vivo. Tumori. 2010; 96: 296-303.
9. Ganai S, Arenas RB, Forbes NS. Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice. Br J Cancer. 2009; 101: 1683-1691.
10. Loeffler M, Le'Negrate G, Krajewska M, Reed JC. IL-18-producing Salmonella inhibit tumor growth. Cancer Gene Ther. 2008; 15: 787-794.
11. Stepanova H, Volf J, Malcova M, et al. Association of attenuated mutants of Salmonella enterica serovar Enteritidis with porcine peripheral blood leukocytes. FEMS Microbiol Lett. 2011; 321: 37-42.
12. VanCott JL, Chatfield SN, Roberts M, et al. Regulation of host immune responses by modification of Salmonella virulence genes. Nat Med. 1998; 4: 1247-1252. (Pubitemid 28512104)
13. Monack DM, Raupach B, Hromockyj AE, Falkow S. Salmonella typhimurium invasion induces apoptosis in infected macrophages. Proc Natl Acad Sci U S A. 1996; 93: 9833-9838. (Pubitemid 26296695)
14. Hersh D, Monack DM, Smith MR, et al. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci USA. 1999; 96: 2396-2401. (Pubitemid 29117926)
15. Kim JM, Eckmann L, Savidge TC, et al. Apoptosis of human intestinal epithelial cells after bacterial invasion. J Clin Invest. 1998; 102: 1815-1823. (Pubitemid 28533828)
16. Brode S, Macary PA. Cross-presentation: dendritic cells and macrophages bite off more than they can chew! Immunology. 2004; 112: 345-351. (Pubitemid 38859511)
17. Kepp O, Tesniere A, Schlemmer F, et al. Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis. 2009; 14: 364-375.
18. Albert ML, Jegathesan M, Darnell RB. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat Immunol. 2001; 2: 1010-1017. (Pubitemid 33069495)
19. Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J Leukoc Biol. 2007; 82: 1365-1374. (Pubitemid 350276946)
20. Jang MJ, Kim JE, Chung YH, et al. Dendritic cells stimulated with outer membrane protein A (OmpA) of Salmonella typhimurium generate effective anti-tumor immunity. Vaccine. 2011; 29: 2400-2410.
21. Avogadri F, Mittal D, Saccheri F, et al. Intra-tumoral Salmonella typhimurium induces a systemic anti-tumor immune response that is directed by low-dose radiation to treat distal disease. Eur J Immunol. 2008; 38: 1937-1947.
22. Saccheri F, Pozzi C, Avogadri F, et al. Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity. Sci Transl Med. 2010; 2: 44ra57.
23. Hoffman RM. Tumor-seeking Salmonella amino acid auxotrophs. Curr Opin Biotechnol. 2011; 22: 917-923.
24. Ganai S, Arenas RB, Sauer JP, et al. In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis. Cancer Gene Ther. 2011; 18: 457-466.
25. Kasinskas RW, Forbes NS. Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro. Biotechnol Bioeng. 2006; 94: 710-721. (Pubitemid 44014201)
26. Zhao M, Yang M, Li XM, et al. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci U S A. 2005; 102: 755-760. (Pubitemid 40282738)
27. Kasinskas RW, Forbes NS. Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis. Cancer Res. 2007; 67: 3201-3209. (Pubitemid 46724858)
28. Hassan R, Ho M. Mesothelin targeted cancer immunotherapy. Eur J Cancer. 2008; 4446-4453.
29. Diaz LA Jr, Cheong I, Foss CA, et al. Pharmacologic and toxicologic evaluation of C. novyi-Nt spores. Toxicol Sci. 2005; 88: 562-575. (Pubitemid 41672164)
30. Clairmont C, Lee KC, Pike J, et al. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J Infect Dis. 2000; 181: 1996-2002. (Pubitemid 30416163)
31. Thamm DH, Kurzman ID, King I, et al. Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation. Clin Cancer Res. 2005; 11: 4827-4834. (Pubitemid 41557202)
32. Toso JF, Gill VJ, Hwu P, et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol. 2002; 20: 142-152. (Pubitemid 34032605)
33. Bereta M, Hayhurst A, Gajda M, et al. Improving tumor targeting and therapeutic potential of Salmonella VNP20009 by displaying cell surface CEA-specific antibodies. Vaccine. 2007; 25: 4183-4192. (Pubitemid 46646963)
34. Jankowska H, Hooper P, Jankowski JA. Aspirin chemoprevention of gastrointestinal cancer in the next decade. A review of the evidence. Pol Arch Med Wewn. 2010; 120: 407-412.